Medicis Pharmaceutical Corporation (MRX)
Q2 2012 Earnings Call
August 8, 2012 5:15 pm ET
Jonah Shacknai – Chairman and Chief Executive Officer
Mark A. Prygocki, Sr. – President
Richard D. Peterson – Executive Vice President, Chief Financial Officer and Treasurer
Christopher T. Schott – JP Morgan Securities Inc.
Greg P. Waterman – Goldman Sachs & Co.
Gary Nachman – Susquehanna Financial Group LLP
Rebecca M. Forest – Piper Jaffray, Inc.
Daniel Chang – Stifel Nicolaus & Company, Inc.
Ken Cacciatore – Cowen and Company, LLC
Shibani Malhotra – RBC Capital Markets Equity Research
Ronny Gal – Sanford C. Bernstein & Co.
Catherine Arnold – Credit Suisse
Douglas D. Tsao – Barclays Capital, Inc.
David Risinger – Morgan Stanley
Stephen Barr Willoughby – Cleveland Research Co.
Thank you for joining the Medicis Second Quarter 2012 Financial Results Conference Call. Today's call is being recorded and webcast live on the company's website at www.medicis.com in the Investor Relations section. And will be available for replay for 10 business days following this call.
This is a brief reminder that all discussions today include forward-looking statements. These statements are based on current assumptions made by Medicis based on historical trends, current conditions, expected future developments, and other factors the company believes appropriate today.
Factors may cause actual results to differ materially from those projected in forward-looking statements. You can find a discussion of these factors and more information about Medicis in the company's filings with the Securities and Exchange Commission. The assumptions underlying the forward-looking statements can change and Medicis disclaims any obligation to update those statements. Please note that references to non-GAAP figures in this webcast are reconciled to GAAP figures as noted in today's press release, which also can be found on the company's website at www.medicis.com.